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Background: Postoperative infections are frequent complications after liver resection and have signifi-
cant impact on length of stay, morbidity and mortality. Surgical site infection (SSI) is the most common
nosocomial infection in surgical patients, accounting for 38% of all such infections.
Objectives: This study aimed to identify predictors of SSI and organ space SSI after liver resection.
Methods: Data from the American College of Surgeons National Surgical Quality Improvement Program
(ACS–NSQIP) database for patients who underwent liver resection in 2005, 2006 or 2007 in any of 173
hospitals throughout the USA were analysed. All patients who underwent a segmental resection, left
hepatectomy, right hepatectomy or trisectionectomy were included.
Results: The ACS–NSQIP database contained 2332 patients who underwent hepatectomy during 2005–
2007. Rates of SSI varied significantly across primary procedures, ranging from 9.7% in segmental
resection patients to 18.3% in trisectionectomy patients. A preoperative open wound, hypernatraemia,
hypoalbuminaemia, elevated serum bilirubin, dialysis and longer operative time were independent pre-
dictors for SSI and for organ space SSI.
Conclusions: These findings may contribute towards the identification of patients at risk for SSI and the
development of strategies to reduce the incidence of SSI and subsequent costs after liver resection.
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Introduction
Postoperative infection is one of the most common complica-
tions after liver resection and has significant impact on length of
stay (LoS), morbidity and mortality.1 Surgical site infections
(SSIs) are the most common nosocomial infections in surgical
patients, accounting for 38% of such infections. Because SSIs
have a severe impact on overall morbidity and costs, in the USA,
the Centers for Disease Control and Prevention (CDC), through
the National Nosocomial Infection Surveillance System (NNISS),
monitor the incidence of SSI. For this purpose, SSI is defined as
an infection with either incisional involvement of skin alone or
with involvement of subcutaneous tissue or organ space. The
NNISS reported an overall incidence of SSI of 2.6% between
2002 and 2004,2 of which two-thirds were incisional and one-
third were organ space infections.
During the last decade, a decreased incidence of perioperative
septic complications has been reported as a result of the use of
advanced surgical techniques, new suturing materials, better
perioperative management and the implementation of infection
surveillance.3 Overall, post-hepatectomy infection rates have been
reported to vary from 4% to 20%1 and incidences of SSI after liver
resection to range between 2.1% and 14.5%.4–7 These cases are
associated with increases in morbidity, mortality and health care
expenses.8
Previous studies have documented increased risk for SSI based
on patient and operative characteristics. The goal of this study was
to identify predictors of SSI after liver resection using data main-
tained by the American College of Surgeons National Surgical
Quality Improvement Program (ACS–NSQIP) and including all
patients who underwent hepatectomies performed at any of 173
centres in the USA between 2005 and 2007.
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Materials and methods
The ACS–NSQIP is a robust reporting system designed to provide
reliable, risk-adjusted surgical outcomes data to surgical services
and administrators at medical centres throughout the private
sector so that surgical quality can be assessed and improved on a
national level.9,10
Data from the Participant Use Data File for all surgical cases
submitted to the ACS–NSQIP in 2005, 2006 and 2007 by 173
hospitals throughout the USA were analysed.
The ACS–NSQIP collects data on 135 variables, including pre-
operative risk factors, intraoperative variables, and 30-day post-
operative morbidity and mortality outcomes for a systematic and
prospective sample of patients undergoing surgical procedures in
both inpatient and outpatient settings. Data are collected in a
standardized fashion according to strict definitions by dedicated
surgical clinical nurse reviewers. Patients are followed throughout
their hospital course and after discharge from hospital for up to 30
days postoperatively. Nurse reviewers collect data from comput-
erized and paper patient medical records and doctor’s office
records, and through telephone interviews with patients. The
accuracy and reproducibility of the data have been previously
demonstrated.9,11,12
CPT-4® (Current Procedural Terminology) codes were
used to select patients who had undergone liver resection,
using primary procedure codes 47120 (segmental resection),
47122 (trisectionectomy), 47125 (left hepatectomy) and 47130
(right hepatectomy). The primary outcome examined was
30-day SSI in subcategories of superficial, deep or organ space
SSI (Table 1). Length of hospital stay and 30-day mortality
outcomes were also analysed. Outcomes were compared across
type of resection using analysis of variance (anova) or chi-
squared tests.
A total of 37 patient demographic, history, review of system
and laboratory values were compared between patients who
developed SSI and those who did not, using chi-squared tests
(for binary variables) or t-tests (for continuous variables).
Because of the increased risk for type I error, a threshold for
significance in these analyses was set at <0.001. Intraoperative
variables [operative duration, transfusion (yes/no) and dirty/
infected wound class] were similarly compared. Independent risk
factors for any SSI and for organ space SSI only were calculated
using multivariable logistic regressions. Preoperative risk vari-
ables were considered for inclusion in a forward stepwise
fashion (P-value for entry: P < 0.05; P-value for exit: P > 0.10).
After independent preoperative risks had been identified,
independent intraoperative variables were identified in a similar
forward stepwise fashion adjusted for the presence of pre-
operative variables.
Results
The ACS–NSQIP database contained 2332 patients who under-
went an open or laparoscopic hepatectomy between 2005 and
2007. Trauma and paediatric cases were excluded from the analy-
sis. The mean  standard deviation patient age was 58.3  13.5
years; 1150 patients (49.3%) were male. Eighteen procedures
(0.8%) were emergent. In 103 patients (4.4%), a bilioenteric anas-
tomosis was performed. A total of 347 patients (14.9%) under-
went concomitant gastrointestinal resection including the
oesophagus, stomach, small bowel, colon and anus.
Surgical site infection rates varied significantly across primary
procedures, ranging from 9.7% in segmental resection patients to
18.3% in trisectionectomy patients (P = 0.001) (Table 2). The
overall incidence of SSI was 11.5%. Univariate analyses (Table 3)
showed SSI occurred more frequently in patients who were male,
smokers, had a preoperative open wound, reduced serum
albumin, elevated bilirubin and elevated alkaline phosphatase.
Intraoperatively, operative duration and transfusion were associ-
Table 1 Definition of surgical site infection (SSI) according to the
National Surgical Quality Improvement Program (NSQIP)
SSI
classification
Definition according to NSQIP
Superficial
incisional
SSI
Infection that occurs within 30 days after the
operation, involves only the skin or subcutaneous
tissue of the incision and shows at least one of the
following characteristics: purulent drainage with or
without laboratory confirmation from the superficial
incision; organisms isolated from an aseptically
obtained culture of fluid or tissue from the superficial
incision; at least one sign of infection; superficial
incision that is deliberately opened by the surgeon
unless incision is culture-negative, or a diagnosis of
superficial incisional SSI made by the surgeon or
attending doctor
Deep
incisional
SSI:
Infection that occurs within 30 days after the
operation, appears to be related to the operation,
involves deep soft tissues of the incision and shows
at least one of the following characteristics: purulent
drainage from the deep incision but not from the
organ space of the surgical site; a deep incision that
spontaneously dehisces or is deliberately opened by
a surgeon when the patient has either fever (>38 °C),
located pain or tenderness unless culture is
negative; an abscess or other evidence of infection
involving the deep incision on direct examination,
during reoperation or by histopathologic or
radiologic examination, or the diagnosis of a deep
incision SSI made by the surgeon or attending
doctor
Organ space
SSI
Infection that occurs within 30 days after the
operation, appears to be related to the operation
and involves any part of the anatomy other than the
incision, which was opened or manipulated during
an operation, and shows at least one of the
following characteristics: purulent drainage from the
drain that is placed through a stab wound into the
organ space; organisms isolated from an aseptically
obtained culture of fluid or tissue from the organ
space; an abscess or other evidence of infection
involving the organ space that is found on direct
examination, during reoperation or by
histopathologic or radiologic examination, or the
diagnosis of an organ space SSI made by the
surgeon or attending doctor
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ated with SSI occurrence. Development of SSI was associated with
a 6.1-day increase in LoS (13.6 days vs. 7.5 days; P < 0.001), a
12.5% increase in the rate of return to the operating room within
30 days (16.0% vs. 3.5%; P < 0.001) and trended towards a 3.1%
increase in mortality (5.2% vs. 2.1%; P = 0.002) (Table 4).
Independent preoperative predictors of SSI from the forward
regression model were (by order of entry) preoperative open
wound/infection, serum sodium > 145 mmol/l, serum albumin
(continuous variable g/dl), total bilirubin > 1.0 mg/dl and opera-
tive duration in minutes. Primary procedure, wound class and
transfusion were not independently significant intraoperative pre-
dictors. The same variables in the same entry order were indepen-
dent predictors of organ space SSI only, with the addition of
dialysis and smoking (Table 5). Rates of organ space SSI by hour
of operative duration are graphed in Fig. 1; the chi-squared test
for linear trend was significant (P < 0.001).
Because the presence of a preoperative open wound was
strongly predictive of SSI in hepatectomy patients, this variable,
for which no specific aetiology is given in the ACS–NSQIP, was
further analysed. The NSQIP describes three common sources of
wound for this variable: (i) a prior operation wound left open and
packed; (ii) a diabetes ulcer, and (iii) a decubitus ulcer. The ACS–
NSQIP did not track data on prior surgery within 30 days until
2006. An examination of hepatectomy cases with preoperative
open wounds in 2006 and 2007 showed three of 16 patients had
undergone prior surgery, six of 16 were diabetes patients, and two
of 16 were completely functionally dependent. These data suggest
a range of preoperative open wound aetiologies.
Discussion
Nosocomial infection continues to represent a major cause of
morbidity, mortality and resource utilization. It is estimated to
occur in around 2.1 million cases per year in the USA.13 Surgical
site infections account for approximately 20% of these
instances.14
The last decade has seen a marked increase in interest in pre-
dictive factors for infectious complications in general surgery.
Most studies have included a variety of different surgical
procedures,15–17 some have analysed many different types of
complication or infection,1,18 and only a few have focused on SSI
in patients undergoing liver resection.3,5
Our study includes 2332 patients who underwent liver resec-
tion in 173 hospitals throughout the USA. Some of the strengths
of the ACS–NSQIP system refer to the large number of patients
included, the strict definition of each and every variable, and the
prospective nature of the database. This dataset records a signifi-
cant amount of procedures performed in a short period of time,
which adds homogeneity to this series.
One interesting finding concerns the correlation between pre-
operative open wounds and SSI. In order to establish the origin of
the preoperative open wound, we investigated patients included in
our series and found that prior open surgery leaving an open
packed wound, decubitus ulcers and diabetes ulcers were equally
distributed. Other related factors identified in previous series as
predictors of SSI after different types of surgical procedures, such
as diabetes mellitus and advanced age, were not significantly asso-
ciated with SSI. Our data suggest that the presence of an open
wound, whether infected or not, anywhere on the body is strongly
associated with the occurrence of SSI in the postoperative period
after hepatectomy. Pessaux et al. reported an increased risk for SSI
in patients diagnosed with a preoperative cutaneous abscess or
skin necrosis after a non-colorectal abdominal procedure.19 They
proposed that a skin infection represents a source of bacteria that
may lead to a secondary deeper infection.19 Our findings support
the recommendation that any open wound should be treated prior
to surgery to decrease the incidence of SSI and subsequent costs.
In some instances, such as in patients with cancer, the timing of
the liver resection could be essential and a risk : benefit approach
should be used.
Several previous reports have addressed the relationship
between operative time and SSI in a wide range of surgical pro-
cedures in general surgery.8,15 In this study, we found a linear
relation between operative time and SSI, suggesting that the
shorter the surgical procedure, the lower the probability of
developing an SSI.
We have previously shown that smoking is an important deter-
minant of resource utilization after liver resection and is associ-
ated with a longer LoS, longer intensive care unit stay and
Table 2 Surgical site infection (SSI) and other outcomes in 2332 hepatectomy patients by primary procedure
Intraoperative variables Primary procedure Chi-squared
P-value47120
SR
47130
RH
47125
LH
47122
TS
All
hepatectomies
Cases, n 1357 512 233 230 2332
Any SSI at 30 days postoperatively 9.7 13.3 11.2 18.3 11.5 0.001
Superficial SSI, % 4.8 4.7 6.4 8.7 5.3 0.074
Deep SSI, % 0.9 1.2 0.9 1.3 1.0 0.896
Organ space SSI, % 4.6 7.8 5.2 10.9 6.0 <0.001
30-day mortality, % 1.8 3.7 0.9 5.2 2.5 0.002
LoS, days, mean  SD 7.5  8.2 9.4  11.0 7.8  6.0 10.3  8.5 8.2  8.8 <0.001
LH, left hepatectomy; RH, right hepatectomy; SR, segmental resection; TS, trisectionectomy; LoS, length of stay; SD, standard deviation.
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increased perioperative mortality.20 This study confirmed a strong
relationship between smoking and the occurrence of SSI, specifi-
cally with organ space SSI.
Hypoalbuminaemia, a well-known marker of liver dys-
function, protein-calorie malnutrition and active acute-phase
response, has been associated with higher incidences of sepsis
and postoperative infection after surgery.8,17,21 Previous studies
have assessed the effect of hypoalbuminaemia as a major predic-
tor of SSI, including deep and organ space infection, in patients
undergoing general surgery procedures.8 In this study, hypoal-
buminaemia was identified as an independent factor associated
with the presence of SSI after hepatectomy, underlining the
Table 3 Preoperative and intraoperative variables by occurrence of surgical site infection (SSI)
Variable All hepatectomy
patients (n = 2332)
Patients without
SSI (n = 2064, 88.5%)
Patients with SSI
(n = 268, 11.5%)
P-value
Age, years, mean  SD 58.3  13.5 58.3  13.7 59.0  12.6 0.399
Male, % 49.3 48.1 58.6 0.001
ASA physical status class, % 0.003
ASA Class III 59.6 58.7 66.4
ASA Class IV 5.0 4.7 7.5
ASA Class V 0.0 0.0 0.0
Smoked within 1 year prior to surgery, % 15.3 14.6 20.5 0.011
Pack-years smoked, mean  SD 12.4  22.2 11.6  21.4 18.4  26.4 <0.001
Medically treated hypertension, % 45.6 44.8 51.5 0.039
BMI class, kg/m2, % 0.002
18.50 2.7 2.6 3.4
18.51–25.00 33.1 33.6 28.6
25.01–30.00 33.1 33.6 28.9
30.01–35.00 19.8 19.4 22.6
35.01–40.00 7.1 6.4 12.8
>40.00 4.2 4.3 3.8
Preoperative functional status, % 0.020
Partially dependent 1.5 1.3 3.4
Fully dependent 0.4 0.4 0.7
History severe COPD, % 3.0 2.7 5.2 0.023
Disseminated cancer, % 41.2 41.9 35.8 0.059
Recent loss of > 10% of body weight, % 5.4 5.0 8.2 0.031
Recent chemotherapy, % 7.9 7.9 7.5 0.783
Recent radiotherapy, % 1.2 1.2 0.7 0.503
Preoperative open wound/infection, % 6.2 0.0 54.1 <0.001
Preoperative systemic inflammation, % 0.054
SIRS 2.0 2.0 2.2
Sepsis 0.3 0.2 1.1
Septic shock 0.3 0.3 0.0
Laboratory values
Preoperative serum albumin, g/dl, mean  SD 4.03  0.57 4.04  0.55 3.92  0.67 0.001
Bilirubin > 1.0, % 11.3 10.6 16.8 0.003
Bilirubin, mg/dl, mean  SD 0.75  1.02 0.71  0.90 1.04  1.62 <0.001
Alkaline phosphatase 123  96 120  89 149  133 <0.001
Haematocrit < 38%, % 33.6 32.9 38.4 0.074
WBC, n/mm3, mean  SD 6963  2874 6902  2844 7430  3062 0.005
Sodium > 145 mmol/l, % 1.0 0.9 2.2 0.037
P < 0.001.
SD, standard deviation; ASA, American Society of Anesthesiologists; BMI, body mass index; COPD, chronic obstructive pulmonary disease; SIRS,
systemic inflammatory response syndrome; WBC, white blood cell count.
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impact of malnutrition and possible liver dysfunction in the
development of septic complications. Other variables related to
hypoalbuminaemia, such as portal hypertension, oesophageal
varices, ascites or prolonged international normalized ratio
(INR) do not seem to predispose to SSI. Hypoalbuminaemia has
been shown to be the only laboratory value associated with an
increased risk for infection and overall morbidity and mortality
in patients undergoing liver resection.1,22 Interestingly, SSI was
also associated with the presence of jaundice, which concords
with findings in other series in which higher morbidity and
mortality rates were reported after hepatectomy in part because
of infection-related complications associated with the preopera-
tive use of biliary stents.23
Although our study did not analyse the increase in costs
related to SSI in patients undergoing liver resection, we found a
strong association between SSI and prolonged LoS and surgical
revision, which represent major components of health care
expenditure. Hospital discharge was delayed by > 6 days and
mortality and reoperation rates were increased substantially, by
3% and 12%, respectively, in the presence of SSI. Weber et al.
compared the costs of hospital care in a group of patients with
and without SSI and identified a statistically significant difference
between the groups which was mainly related to longer postop-
erative LoS and antibiotics administration.24 However, Weber
et al.24 included only in-hospital incidences of SSI and thereby
excluded patients diagnosed in an outpatient setting who did not
require hospitalization. Alfonso et al. performed a similar study
including both in-hospital and extra-hospital costs and thus both
the direct and indirect costs of SSI to show its impact on resource
utilization.25
There are several limitations to this study. Firstly, our data did
not include information on the use of prophylactic antibiotics.
Table 4 Intraoperative characteristics, length of stay and mortality by surgical site infection (SSI) occurrence
Variable All hepatectomy patients
(n = 2332)
Patients without SSI
(n = 2064, 88.5%)
Patients with SSI
(n = 268, 11.5%)
P-value
Wound class dirty/infected, % 5.5 5.1 8.2 0.038
Operative duration, min, mean  SD 253  122 247  120 299  132 <0.001
Transfused intraoperatively <0.001
1–2 units PRBCs, % 14.1 14.2 13.9
3 units PRBCs, % 14.8 13.6 24.0
Length of stay, days, mean  SD 8.2  8.8 7.5  7.6 13.6  14.1 <0.001
Return to OR within 30 days of surgery, % 5.0 3.5 16.0 <0.001
Mortality, % 2.5 2.1 5.2 0.002
P < 0.001.
SD, standard deviation; PRBCs, packed red blood cells; OR, operating room.
Table 5 Independent predictors of surgical site infection (SSI) in 2332 hepatectomy patients
Variable Multivariate odds ratio (95% confidence interval, P-value)
Superficial, deep or organ
space SSI (n = 268, 11.5%)
Organ space SSI only
(n = 140, 6.0%)
Preoperative open wound/infection All patients with this variable had SSIa 1.81 (1.03–3.20, P = 0.039)
Serum sodium > 145 mmol/l 6.05 (2.30–15.93, P < 0.001) 6.25 (2.36–16.55, P < 0.001)
Serum albumin, per mg/dl from mean 0.67 (0.49–0.91, P = 0.011) 0.70 (0.52–0.95, P = 0.022)
Total bilirubin > 1.0 1.70 (1.05–2.77, P = 0.032) 1.87 (1.19–2.95, P = 0.007)
On dialysis Not in model 4.46 (1.14–17.45, P = 0.032)
Smoker within 1 year of procedure Not in model 1.66 (1.08–2.54, P = 0.021)
Operative time, per min from mean 1.003 (1.001–1.004, P < 0.001) 1.003 (1.002–1.004, P < 0.001)
aBecause all patients with this variable experienced SSI, the odds ratio was extremely large (>100). No precise odds ratio is estimable from this patient
population; however, it is clearly a strong predictor.
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Figure 1 Incidence of organ space surgical site infection by hour of
operative duration
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Although the utilization of prophylactic antibiotics is considered
standard in this type of surgery and was probably applied in
most cases, the type and duration of medication were not
recorded. Although the use of i.v. antibiotics prior to skin inci-
sion has been related to a lower incidence of wound infection, its
applicability as prophylaxis in deep SSI has not been proven. We
were able to demonstrate several factors strongly associated with
superficial and deep SSI using a multicentre design with a large
number of patients, which may offset any site-specific factors
and thereby accurately reflect national trends. Secondly, the
NSQIP database was developed to evaluate a wide variety of dif-
ferent surgical interventions and does not include data on
procedure-specific details, such as the utilization of stents or
drains prior to surgery, which may be associated with an
increased risk for infection.
In summary, the present study has identified the preoperative
presence of an open wound, hypernatraemia, hypoalbuminaemia,
elevated serum bilirubin, dialysis and longer operative time as
independent predictors for SSI and for organ space SSI in patients
undergoing liver resection. The intention to correct these factors
prior to surgery should impact on the incidence of SSI and
decrease mortality, LoS and ultimately costs.
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